Common Contracts
5 similar Sales Agreement contracts by INSMED Inc, 89bio, Inc., Applied Molecular Transport Inc., Pharvaris N.V.
PHARVARIS N.V. Ordinary Shares (nominal value of €0.12 per share) SALES AGREEMENTSales Agreement • April 12th, 2024 • Pharvaris N.V. • Pharmaceutical preparations • New York
Pharvaris N.V., a public limited liability company (naamloze vennootschap) (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:
SALES AGREEMENTSales Agreement • February 22nd, 2024 • INSMED Inc • Pharmaceutical preparations • New York
Insmed Incorporated, a Virginia corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:
APPLIED MOLECULAR TRANSPORT INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • January 28th, 2022 • Applied Molecular Transport Inc. • Pharmaceutical preparations • New York
Applied Molecular Transport Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and JMP Securities LLC (collectively the “Agents,” and each individually an “Agent”), as follows:
89bio, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • March 25th, 2021 • 89bio, Inc. • Pharmaceutical preparations • New York
89bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (collectively the “Agents,” and each individually an “Agent”), as follows:
SALES AGREEMENTSales Agreement • February 25th, 2021 • INSMED Inc • Pharmaceutical preparations • New York
Insmed Incorporated, a Virginia corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
